No mate, Sept 2020 was selloff. This is just nervous nellies getting fleeced by instos in the volatile world of biotech.
R&D credit to come, oppies to be converted and upfront cash likely coming in the next deal.
Ann: Quarterly Appendix 4C and Activities Report, page-45
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.010(2.30%) |
Mkt cap ! $245.0M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 46.0¢ | 44.0¢ | $882.2K | 1.961M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 55281 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 27933 | 2 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |